nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Angioedema—Sorafenib—thyroid cancer	0.00203	0.00203	CcSEcCtD
Guanabenz—Syncope—Sorafenib—thyroid cancer	0.00199	0.00199	CcSEcCtD
Guanabenz—Leukopenia—Sorafenib—thyroid cancer	0.00199	0.00199	CcSEcCtD
Guanabenz—Bone pain—Epirubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Guanabenz—Loss of consciousness—Sorafenib—thyroid cancer	0.00195	0.00195	CcSEcCtD
Guanabenz—Cough—Sorafenib—thyroid cancer	0.00194	0.00194	CcSEcCtD
Guanabenz—Inflammation—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Guanabenz—Asthenia—Vandetanib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Guanabenz—Skin discolouration—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Guanabenz—Hypertension—Sorafenib—thyroid cancer	0.00192	0.00192	CcSEcCtD
Guanabenz—Pruritus—Vandetanib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Guanabenz—Neck pain—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Guanabenz—Musculoskeletal pain—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Guanabenz—Hypocalcaemia—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Guanabenz—Thinking abnormal—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Guanabenz—Arthralgia—Sorafenib—thyroid cancer	0.00189	0.00189	CcSEcCtD
Guanabenz—Myalgia—Sorafenib—thyroid cancer	0.00189	0.00189	CcSEcCtD
Guanabenz—Oliguria—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Guanabenz—Hiccups—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Guanabenz—Dry mouth—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Guanabenz—Diarrhoea—Vandetanib—thyroid cancer	0.00184	0.00184	CcSEcCtD
Guanabenz—Bone pain—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Guanabenz—Infection—Sorafenib—thyroid cancer	0.0018	0.0018	CcSEcCtD
Guanabenz—Skin exfoliation—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Guanabenz—Inflammation—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Guanabenz—Shock—Sorafenib—thyroid cancer	0.00178	0.00178	CcSEcCtD
Guanabenz—Nervous system disorder—Sorafenib—thyroid cancer	0.00178	0.00178	CcSEcCtD
Guanabenz—Dizziness—Vandetanib—thyroid cancer	0.00177	0.00177	CcSEcCtD
Guanabenz—Thrombocytopenia—Sorafenib—thyroid cancer	0.00177	0.00177	CcSEcCtD
Guanabenz—Skin disorder—Sorafenib—thyroid cancer	0.00176	0.00176	CcSEcCtD
Guanabenz—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Guanabenz—Neck pain—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Guanabenz—Hiccups—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Guanabenz—Anorexia—Sorafenib—thyroid cancer	0.00173	0.00173	CcSEcCtD
Guanabenz—Vomiting—Vandetanib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Guanabenz—Rash maculo-papular—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Guanabenz—Rash—Vandetanib—thyroid cancer	0.00169	0.00169	CcSEcCtD
Guanabenz—Dermatitis—Vandetanib—thyroid cancer	0.00169	0.00169	CcSEcCtD
Guanabenz—Headache—Vandetanib—thyroid cancer	0.00168	0.00168	CcSEcCtD
Guanabenz—Pulmonary oedema—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Guanabenz—Skin exfoliation—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Guanabenz—Mental disability—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Guanabenz—Dyspnoea—Sorafenib—thyroid cancer	0.00161	0.00161	CcSEcCtD
Guanabenz—Nausea—Vandetanib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Guanabenz—Dyspepsia—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Guanabenz—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Guanabenz—Decreased appetite—Sorafenib—thyroid cancer	0.00157	0.00157	CcSEcCtD
Guanabenz—Diabetes mellitus—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00156	0.00156	CcSEcCtD
Guanabenz—Fatigue—Sorafenib—thyroid cancer	0.00156	0.00156	CcSEcCtD
Guanabenz—Pain—Sorafenib—thyroid cancer	0.00155	0.00155	CcSEcCtD
Guanabenz—Constipation—Sorafenib—thyroid cancer	0.00155	0.00155	CcSEcCtD
Guanabenz—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Guanabenz—Eczema—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Guanabenz—Mental disability—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Guanabenz—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00148	0.00148	CcSEcCtD
Guanabenz—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Guanabenz—Urticaria—Sorafenib—thyroid cancer	0.00144	0.00144	CcSEcCtD
Guanabenz—Body temperature increased—Sorafenib—thyroid cancer	0.00143	0.00143	CcSEcCtD
Guanabenz—Abdominal pain—Sorafenib—thyroid cancer	0.00143	0.00143	CcSEcCtD
Guanabenz—Dermatitis bullous—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Guanabenz—Eczema—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Guanabenz—Hypoglycaemia—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Guanabenz—Cardiac failure—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Guanabenz—Hyponatraemia—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Guanabenz—Hypersensitivity—Sorafenib—thyroid cancer	0.00133	0.00133	CcSEcCtD
Guanabenz—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Guanabenz—Face oedema—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Guanabenz—Asthenia—Sorafenib—thyroid cancer	0.0013	0.0013	CcSEcCtD
Guanabenz—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Guanabenz—Cardiac failure—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Guanabenz—Pruritus—Sorafenib—thyroid cancer	0.00128	0.00128	CcSEcCtD
Guanabenz—Dehydration—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Guanabenz—Hyponatraemia—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Guanabenz—Liver function test abnormal—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Guanabenz—Dry skin—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Guanabenz—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Guanabenz—Hypokalaemia—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Guanabenz—Diarrhoea—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Guanabenz—Breast disorder—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Guanabenz—Face oedema—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Guanabenz—Gastritis—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Guanabenz—Dizziness—Sorafenib—thyroid cancer	0.0012	0.0012	CcSEcCtD
Guanabenz—Abdominal distension—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Guanabenz—Influenza—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Guanabenz—Dehydration—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Guanabenz—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Guanabenz—Dry skin—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Guanabenz—Vomiting—Sorafenib—thyroid cancer	0.00115	0.00115	CcSEcCtD
Guanabenz—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Guanabenz—Hypokalaemia—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Guanabenz—Rash—Sorafenib—thyroid cancer	0.00114	0.00114	CcSEcCtD
Guanabenz—Dermatitis—Sorafenib—thyroid cancer	0.00114	0.00114	CcSEcCtD
Guanabenz—Breast disorder—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Guanabenz—Headache—Sorafenib—thyroid cancer	0.00113	0.00113	CcSEcCtD
Guanabenz—Gastritis—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Guanabenz—Abdominal distension—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Guanabenz—Influenza—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Guanabenz—Nausea—Sorafenib—thyroid cancer	0.00108	0.00108	CcSEcCtD
Guanabenz—Weight increased—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Guanabenz—Weight decreased—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Guanabenz—Hyperglycaemia—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Guanabenz—Infestation NOS—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Guanabenz—Infestation—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Guanabenz—Weight increased—Doxorubicin—thyroid cancer	0.000991	0.000991	CcSEcCtD
Guanabenz—Weight decreased—Doxorubicin—thyroid cancer	0.000985	0.000985	CcSEcCtD
Guanabenz—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Guanabenz—Infestation NOS—Doxorubicin—thyroid cancer	0.000971	0.000971	CcSEcCtD
Guanabenz—Infestation—Doxorubicin—thyroid cancer	0.000971	0.000971	CcSEcCtD
Guanabenz—Haemoglobin—Epirubicin—thyroid cancer	0.000947	0.000947	CcSEcCtD
Guanabenz—Haemorrhage—Epirubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
Guanabenz—Oedema peripheral—Epirubicin—thyroid cancer	0.000928	0.000928	CcSEcCtD
Guanabenz—Connective tissue disorder—Epirubicin—thyroid cancer	0.000926	0.000926	CcSEcCtD
Guanabenz—Erythema multiforme—Epirubicin—thyroid cancer	0.000891	0.000891	CcSEcCtD
Guanabenz—Eye disorder—Epirubicin—thyroid cancer	0.00088	0.00088	CcSEcCtD
Guanabenz—Tinnitus—Epirubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Guanabenz—Haemoglobin—Doxorubicin—thyroid cancer	0.000876	0.000876	CcSEcCtD
Guanabenz—Haemorrhage—Doxorubicin—thyroid cancer	0.000871	0.000871	CcSEcCtD
Guanabenz—Oedema peripheral—Doxorubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Guanabenz—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000856	0.000856	CcSEcCtD
Guanabenz—Immune system disorder—Epirubicin—thyroid cancer	0.000851	0.000851	CcSEcCtD
Guanabenz—Mediastinal disorder—Epirubicin—thyroid cancer	0.000849	0.000849	CcSEcCtD
Guanabenz—Chills—Epirubicin—thyroid cancer	0.000845	0.000845	CcSEcCtD
Guanabenz—Erythema multiforme—Doxorubicin—thyroid cancer	0.000824	0.000824	CcSEcCtD
Guanabenz—Erythema—Epirubicin—thyroid cancer	0.00082	0.00082	CcSEcCtD
Guanabenz—Malnutrition—Epirubicin—thyroid cancer	0.00082	0.00082	CcSEcCtD
Guanabenz—Eye disorder—Doxorubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Guanabenz—Tinnitus—Doxorubicin—thyroid cancer	0.000813	0.000813	CcSEcCtD
Guanabenz—Flatulence—Epirubicin—thyroid cancer	0.000808	0.000808	CcSEcCtD
Guanabenz—Tension—Epirubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Guanabenz—Nervousness—Epirubicin—thyroid cancer	0.000796	0.000796	CcSEcCtD
Guanabenz—Back pain—Epirubicin—thyroid cancer	0.000793	0.000793	CcSEcCtD
Guanabenz—Muscle spasms—Epirubicin—thyroid cancer	0.000788	0.000788	CcSEcCtD
Guanabenz—Immune system disorder—Doxorubicin—thyroid cancer	0.000787	0.000787	CcSEcCtD
Guanabenz—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Guanabenz—Chills—Doxorubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Guanabenz—Vision blurred—Epirubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Guanabenz—Ill-defined disorder—Epirubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Guanabenz—Erythema—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Guanabenz—Malnutrition—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Guanabenz—Anaemia—Epirubicin—thyroid cancer	0.000758	0.000758	CcSEcCtD
Guanabenz—Agitation—Epirubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Guanabenz—Flatulence—Doxorubicin—thyroid cancer	0.000748	0.000748	CcSEcCtD
Guanabenz—Tension—Doxorubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Guanabenz—Malaise—Epirubicin—thyroid cancer	0.000739	0.000739	CcSEcCtD
Guanabenz—Nervousness—Doxorubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Guanabenz—Syncope—Epirubicin—thyroid cancer	0.000735	0.000735	CcSEcCtD
Guanabenz—Leukopenia—Epirubicin—thyroid cancer	0.000734	0.000734	CcSEcCtD
Guanabenz—Back pain—Doxorubicin—thyroid cancer	0.000734	0.000734	CcSEcCtD
Guanabenz—Muscle spasms—Doxorubicin—thyroid cancer	0.000729	0.000729	CcSEcCtD
Guanabenz—Loss of consciousness—Epirubicin—thyroid cancer	0.000721	0.000721	CcSEcCtD
Guanabenz—Cough—Epirubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Guanabenz—Vision blurred—Doxorubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Guanabenz—Hypertension—Epirubicin—thyroid cancer	0.000708	0.000708	CcSEcCtD
Guanabenz—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000704	0.000704	CcSEcCtD
Guanabenz—Anaemia—Doxorubicin—thyroid cancer	0.000701	0.000701	CcSEcCtD
Guanabenz—Myalgia—Epirubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Guanabenz—Arthralgia—Epirubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Guanabenz—Chest pain—Epirubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Guanabenz—Agitation—Doxorubicin—thyroid cancer	0.000697	0.000697	CcSEcCtD
Guanabenz—Anxiety—Epirubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Guanabenz—Discomfort—Epirubicin—thyroid cancer	0.00069	0.00069	CcSEcCtD
Guanabenz—Malaise—Doxorubicin—thyroid cancer	0.000684	0.000684	CcSEcCtD
Guanabenz—Dry mouth—Epirubicin—thyroid cancer	0.000683	0.000683	CcSEcCtD
Guanabenz—Syncope—Doxorubicin—thyroid cancer	0.00068	0.00068	CcSEcCtD
Guanabenz—Leukopenia—Doxorubicin—thyroid cancer	0.000679	0.000679	CcSEcCtD
Guanabenz—Confusional state—Epirubicin—thyroid cancer	0.000675	0.000675	CcSEcCtD
Guanabenz—Oedema—Epirubicin—thyroid cancer	0.000669	0.000669	CcSEcCtD
Guanabenz—Loss of consciousness—Doxorubicin—thyroid cancer	0.000667	0.000667	CcSEcCtD
Guanabenz—Infection—Epirubicin—thyroid cancer	0.000665	0.000665	CcSEcCtD
Guanabenz—Cough—Doxorubicin—thyroid cancer	0.000662	0.000662	CcSEcCtD
Guanabenz—Shock—Epirubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Guanabenz—Nervous system disorder—Epirubicin—thyroid cancer	0.000656	0.000656	CcSEcCtD
Guanabenz—Thrombocytopenia—Epirubicin—thyroid cancer	0.000655	0.000655	CcSEcCtD
Guanabenz—Hypertension—Doxorubicin—thyroid cancer	0.000655	0.000655	CcSEcCtD
Guanabenz—Tachycardia—Epirubicin—thyroid cancer	0.000653	0.000653	CcSEcCtD
Guanabenz—Skin disorder—Epirubicin—thyroid cancer	0.00065	0.00065	CcSEcCtD
Guanabenz—Chest pain—Doxorubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Guanabenz—Myalgia—Doxorubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Guanabenz—Arthralgia—Doxorubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Guanabenz—Anxiety—Doxorubicin—thyroid cancer	0.000644	0.000644	CcSEcCtD
Guanabenz—Discomfort—Doxorubicin—thyroid cancer	0.000638	0.000638	CcSEcCtD
Guanabenz—Anorexia—Epirubicin—thyroid cancer	0.000638	0.000638	CcSEcCtD
Guanabenz—Dry mouth—Doxorubicin—thyroid cancer	0.000632	0.000632	CcSEcCtD
Guanabenz—Hypotension—Epirubicin—thyroid cancer	0.000625	0.000625	CcSEcCtD
Guanabenz—Confusional state—Doxorubicin—thyroid cancer	0.000624	0.000624	CcSEcCtD
Guanabenz—Oedema—Doxorubicin—thyroid cancer	0.000619	0.000619	CcSEcCtD
Guanabenz—Infection—Doxorubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00061	0.00061	CcSEcCtD
Guanabenz—Shock—Doxorubicin—thyroid cancer	0.000609	0.000609	CcSEcCtD
Guanabenz—Nervous system disorder—Doxorubicin—thyroid cancer	0.000607	0.000607	CcSEcCtD
Guanabenz—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000606	0.000606	CcSEcCtD
Guanabenz—Tachycardia—Doxorubicin—thyroid cancer	0.000604	0.000604	CcSEcCtD
Guanabenz—Skin disorder—Doxorubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Guanabenz—Paraesthesia—Epirubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Guanabenz—Dyspnoea—Epirubicin—thyroid cancer	0.000597	0.000597	CcSEcCtD
Guanabenz—Anorexia—Doxorubicin—thyroid cancer	0.00059	0.00059	CcSEcCtD
Guanabenz—Dyspepsia—Epirubicin—thyroid cancer	0.000589	0.000589	CcSEcCtD
Guanabenz—Decreased appetite—Epirubicin—thyroid cancer	0.000582	0.000582	CcSEcCtD
Guanabenz—Hypotension—Doxorubicin—thyroid cancer	0.000579	0.000579	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000578	0.000578	CcSEcCtD
Guanabenz—Fatigue—Epirubicin—thyroid cancer	0.000577	0.000577	CcSEcCtD
Guanabenz—Pain—Epirubicin—thyroid cancer	0.000572	0.000572	CcSEcCtD
Guanabenz—Constipation—Epirubicin—thyroid cancer	0.000572	0.000572	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000564	0.000564	CcSEcCtD
Guanabenz—Paraesthesia—Doxorubicin—thyroid cancer	0.000556	0.000556	CcSEcCtD
Guanabenz—Dyspnoea—Doxorubicin—thyroid cancer	0.000552	0.000552	CcSEcCtD
Guanabenz—Feeling abnormal—Epirubicin—thyroid cancer	0.000551	0.000551	CcSEcCtD
Guanabenz—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000547	0.000547	CcSEcCtD
Guanabenz—Dyspepsia—Doxorubicin—thyroid cancer	0.000545	0.000545	CcSEcCtD
Guanabenz—Decreased appetite—Doxorubicin—thyroid cancer	0.000538	0.000538	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000535	0.000535	CcSEcCtD
Guanabenz—Fatigue—Doxorubicin—thyroid cancer	0.000534	0.000534	CcSEcCtD
Guanabenz—Urticaria—Epirubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
Guanabenz—Pain—Doxorubicin—thyroid cancer	0.000529	0.000529	CcSEcCtD
Guanabenz—Constipation—Doxorubicin—thyroid cancer	0.000529	0.000529	CcSEcCtD
Guanabenz—Abdominal pain—Epirubicin—thyroid cancer	0.000529	0.000529	CcSEcCtD
Guanabenz—Body temperature increased—Epirubicin—thyroid cancer	0.000529	0.000529	CcSEcCtD
Guanabenz—Feeling abnormal—Doxorubicin—thyroid cancer	0.00051	0.00051	CcSEcCtD
Guanabenz—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000506	0.000506	CcSEcCtD
Guanabenz—Hypersensitivity—Epirubicin—thyroid cancer	0.000493	0.000493	CcSEcCtD
Guanabenz—Urticaria—Doxorubicin—thyroid cancer	0.000492	0.000492	CcSEcCtD
Guanabenz—Body temperature increased—Doxorubicin—thyroid cancer	0.000489	0.000489	CcSEcCtD
Guanabenz—Abdominal pain—Doxorubicin—thyroid cancer	0.000489	0.000489	CcSEcCtD
Guanabenz—Asthenia—Epirubicin—thyroid cancer	0.00048	0.00048	CcSEcCtD
Guanabenz—Pruritus—Epirubicin—thyroid cancer	0.000473	0.000473	CcSEcCtD
Guanabenz—Diarrhoea—Epirubicin—thyroid cancer	0.000458	0.000458	CcSEcCtD
Guanabenz—Hypersensitivity—Doxorubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Guanabenz—Asthenia—Doxorubicin—thyroid cancer	0.000444	0.000444	CcSEcCtD
Guanabenz—Dizziness—Epirubicin—thyroid cancer	0.000442	0.000442	CcSEcCtD
Guanabenz—Pruritus—Doxorubicin—thyroid cancer	0.000438	0.000438	CcSEcCtD
Guanabenz—Vomiting—Epirubicin—thyroid cancer	0.000425	0.000425	CcSEcCtD
Guanabenz—Diarrhoea—Doxorubicin—thyroid cancer	0.000424	0.000424	CcSEcCtD
Guanabenz—Rash—Epirubicin—thyroid cancer	0.000422	0.000422	CcSEcCtD
Guanabenz—Dermatitis—Epirubicin—thyroid cancer	0.000422	0.000422	CcSEcCtD
Guanabenz—Headache—Epirubicin—thyroid cancer	0.000419	0.000419	CcSEcCtD
Guanabenz—Dizziness—Doxorubicin—thyroid cancer	0.000409	0.000409	CcSEcCtD
Guanabenz—Nausea—Epirubicin—thyroid cancer	0.000397	0.000397	CcSEcCtD
Guanabenz—Vomiting—Doxorubicin—thyroid cancer	0.000394	0.000394	CcSEcCtD
Guanabenz—Rash—Doxorubicin—thyroid cancer	0.00039	0.00039	CcSEcCtD
Guanabenz—Dermatitis—Doxorubicin—thyroid cancer	0.00039	0.00039	CcSEcCtD
Guanabenz—Headache—Doxorubicin—thyroid cancer	0.000388	0.000388	CcSEcCtD
Guanabenz—Nausea—Doxorubicin—thyroid cancer	0.000368	0.000368	CcSEcCtD
